Cipla aims to make the drug accessible to all and empower millions to take control of their health with greater ease. ‘A breath of fresh air for #diabetes_management! Inhaled #insulin ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cialis and its generic counterpart, tadalafil, have Food and Drug Administration (FDA) approval to treat erectile dysfunction. Learn more about our most trusted places to get this medication ...

Shares of Cipla Limited climbed 1.91 per cent and traded at Rs 1478.60 apiece, at around 11:40 pm. The stock opened in green at Rs 1455 vs the previous closure of Rs 1450.85. More than 10.44 lakh ...

After a lengthy questionnaire, our tester was recommended Hims Hard Mints tadalafil (generic for Cialis). Aaron noted that the questionnaire felt very long and didn’t indicate how many questions ...

Mumbai-based pharmaceutical giant Cipla will distribute and market the drug in India. Inhaled from the mouth at the beginning of a meal, Afrezza dissolves rapidly into the lungs and delivers ...

Cipla is currently trading at Rs 1496.10, with a percentage change of 0.32% today. The 7-day exponential moving average is Rs 1492.90. Cipla is currently trading at Rs 1492.20, showing a slight ...

Cipla shares rose 2.4 per cent in trade and recorded an intraday high at Rs 1,483.4 per share on BSE. On NSE, 1.022 million shares changed hands, while on BSE 0.019 million shares were traded. Around ...

Cipla is currently trading at Rs 1528.3, with a slight uptick of 0.46% today, and has delivered a return of 3.32% over the past six months. Cipla is currently valued at Rs 1530.1, experiencing a gain ...

Cipla Ltd.'s share price rose to become the top gainer on the NSE Nifty 50 index on Tuesday after Kotak Securities upgraded the stock rating to 'buy' from 'add'. The brokerage expects recovery in the ...

Cipla rolls out mobile application for asthma screening India has a three-fold higher mortality rate and two-fold higher asthma-associated disability burden compared to the global proportion. PTI ...